SEC Tracker
Get the app

GLAUKOS GKOS

InterWest Venture Management (Entity controlled by GKOS Director, Gilbert Kliman) plans to sell 16,347 GKOS shares, about $1.5M

Form
144
Filed
Importance
Routine
Document
Form 144
  1. Approximate sale date: Feb 27, 2024
  2. Broker: Merrill Lynch
  3. Shares acquired by: Received for no consideration from Gilbert Kliman pursuant to an agreement with respect to compensation Mr. Kliman received from the Issuer for board service.; Received for no consideration from Gilbert Kliman pursuant to an agreement with respect to compensation Mr. Kliman received from Avedro for board service.

All of InterWest Venture Management's insider filings, holdings and planned sales

Written from the Form 144 on EDGAR. AI can make mistakes. Check the filing.

Open in the appGet the appView on EDGAR

Get an email when GLAUKOS files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 3841 and related industry codes: the same peer list as the financial tables.

  1. Merit Medical Systems MMSI public float $5.4B, Jun 30, 2025
  2. MSA Safety MSA public float $6.5B, Jun 30, 2025
  3. Globus Medical GMED public float $6.6B, Jun 30, 2025
  4. iRhythm Holdings IRTC public float $4.9B, Jun 30, 2025
  5. TransMedics Group TMDX public float $4.4B, Jun 30, 2025

Data on this page was fetched . The filing on SEC.gov is the record.